Bangkok Dusit Medical Services Public Company Limited was established on 30th October 1969 under the name "Bangkok Dusit Medical Services Company Limited" with initial registered capital of Baht 10 million. On 26th February 1972, Bangkok Hospital commenced operations in providing medical services. Through business expansion, the Company was listed on the Stock Exchange of Thailand on 2nd October 1991 and registered its conversion to public company limited in 1994. As of October 2013 has a registered capital of Baht 1,700.00 million, with paid-up capital of Baht 1,549.09 million.

Significant events in the past years


The Company invested in Krungthon Hospital Public Company Limited "KDH", a company listed on the Stock Exchange of Thailand and operating a 150-bed private hospital, by acquiring shares from existing shareholders of KDH with initial investment equal to 16.82% of registered and paid-up capital of KDH. Later, the Company acquired additional shares through the Stock Exchange of Thailand, resulting in total number of shares held equal to 20.01% of registered and paid-up capital of KDH.

The Company increased capital in Greenline Synergy Company Limited, a subsidiary in which the Company holds 100%, from Baht 30 million to Baht 200 million in order to improve information technology services provided to the Group.

Wattanosoth Hospital, the cancer hospital, opened the Bangkok Hematology Center on 20th August 2010 to provide medical care to patients with blood disease by a team of hematology physicians and diagnosis laboratory which meets high standards, as well as a blood bank to store and reserve blood. The Bangkok Hematology Center provides efficient holistic medical care to patients with blood disease.

The Company went through some restructuring. On 28th October 2010, the Company executed an Entire Business Transfer of Bangkok Hospital Hua Hin Company Limited, a subsidiary in which the Company holds 100% and was established as a 60-bed private hospital in Hua Hin, Prachuabkirikhan Province. The purpose of the Entire Business Transfer was to transfer operations of the Bangkok Hospital Hua Hin from the subsidiary to Bangkok Dusit Medical Services Public Company Limited, as a branch of Bangkok Hospital in Hua Hin, in order to reduce management costs and increase flexibility in management of operations and resources, especially in management of medical personnel, which will increase operational efficiency to meet the Company's policy.
The Bangkok Hospital Hua Hin is an investment project which received support from the Board of Investment. The investment capital is approximately Baht 850 million. On the day of the entire business transfer, Bangkok Hospital Hua Hin was still under construction and not yet in operation. After the transfer of the business and all assets to the parent company, the Bangkok Hospital Hua Hin Company Limited registered the closing of the business on 5th November 2010 and is currently in the liquidation process.

The Company increased capital in Royal Bangkok Healthcare Company Limited, a subsidiary in which the Company holds 100%, from initial registered capital of Baht 1.0 million to Baht 736.0 million. The increased capital was used to acquire all shares of A.N.B. Laboratories Company Limited ("ANB") from existing shareholders on 1st December 2010 with total investment of Baht 734.0 million. ANB is the 4th largest producer of saline in the country. In addition, the company also produces and distributes medicine and medical supplies with exports equaling about 20% of total sales.

The Board of Directors' special agenda meeting 2/2010 on 14th December 2010 approved the merger of the Company and Health Network Public Company Limited (Phyathai Hospital Group and Paolo Hospital Group) through an Entire Business Transfer of Health Network Public Company Limited, which is majority held by Mr. Wichai Tongtang and family. The Company shall pay a total of no more than Baht 9,825,357,789 for the merger, comprised of newly issued common shares of the Company in the amount of no more than 230,870,405 shares at Baht 37.75 per share, equal to no more than Baht 8,715,357,789 and cash of approximately Baht 680,000,000, as well as transfer of load debt and interest incurred from Health Network in the amount of no more than Baht 430,000,000.

The Company invested in an Open MRI 1.0 T, the only such machine in Thailand. Patients do not need to enter the tunnel when getting a scan as before, which greatly reduces patient's anxiety of confined spaces and does not require anesthesia.

The Bangkok Spine Academy has performed minimal invasive spine surgery using a microscope to reduce pain and blood loss and for faster recuperation.

The Bangkok Heart Hospital and the Pacific Rim Electrophysiology Research Institute established the "Pacific Rim Electrophysiology Research Institute at Bangkok Hospital" and the "Cardiac Electrophysiology Clinic" headed by Dr. Koonlawee Nademanee, an American Board cardiologist specializing in cardiac electrophysiology. The Institute provides diagnosis and treatment of a variety of irregular heart rhythms (cardiac arrhythmias) using catheter ablation, electrophysiology and cardiac device implantation.

The Company invested in the Bi-plane DSA used in diagnosis and treatment of strokes and other blood vessels with visual effects using 2 megapixel digital imaging. The technology enables doctors to more efficiently diagnose by creating 3 dimension imaging, which can clearly show blood vessels that are as thin as a strand of hair.

In February 2011, the Company invested in 46,116,400 common shares of Bumrungrad Hospital Public Company Limited ("BH"), equal to 6.32% of outstanding shares sold of BH, as well as invested in 35,000,000 units of NVDR or 4.79% of shares outstanding of BH. The Company later exercised the 1:1 conversion of NVDR to common shares, as well as invested in additional common shares of BH. Presently, the Company holds 103,827,600 shares or 14.25% of shares outstanding of Bumrungrad Hospital Public Company Limited.

The Company registered additional capital of Baht 1,481,034,024 on 1st April 2011 to pay for the entire business transfer of Health Network Public Company Limited in accordance with the Extraordinary Meeting of the Shareholders 1/2011 on 24th February 2011. This resulted in the Company holding 68.64% from 19.47% of Prasit Pattana Public Company Limited (Phyathai Hospital Group: Phyathai Hospital 1-3 and Phyathai Hospital Sriracha). In addition, the Company now holds shares of 4 companies within the Paolo Memorial Hospital Group, namely, 100% of Paolo Medic Company Limited (Paolo Memorial Hospital Phaholyotin), 88.73% of Paolo Samutrprakarn Company Limited (Paolo Memorial Hospital Samutrprakarn), 80.72% of Siam Medical Company Limited (Paolo Memorial Hospital Chokchai 4) and 99.76% of Thai Medical Center Public Company Limited (Paolo Memorial Hospital Nawamintr). Consequently, after the mergers, the Company now has 27 hospitals in the Group, from 19 (25 hospitals in Thailand and 2 hospitals in Cambodia), with a total of 4,987 beds, up from 3,193 beds.

The Company made a tender offer on Prasit Pattana Public Company Limited ("PYT") with a period of 25 business days from 8th April to 23rd May 2011. Payment was offered in two ways, namely, Baht 3.71 cash per share or common shares of the Company ("BDMS") at 10.1706 PYT shares for 1 BDMS share. The respondents must choose either option.
After the tender offer, the Company held 97.10% of PYT outstanding shares, up from 68.64%. The Company issued 64,366,277 rights shares to respondents who chose to receive BDMS shares, resulting in Baht 1,545,400,481 of paid-up capital from Baht 1,481,034,024.

The Company increased paid-up capital by another Baht 58,200 to accommodate the conversion of the convertible bonds to common shares of the Company, resulting in a paid-up capital of Baht 1,545,458,883. The convertible bonds matured in July 2011, therefore, the Company no longer has any convertible bond obligations.

The Company invested in an additional 1,474,000 common shares of Udon Pattana (1994) Company Limited (Ake Udon Hospital) equal to 4.9%, resulting in 4,474,000 shares or 14.9% of shares outstanding, up from 3,000,000 shares or 10%. When including ownership of Udon Pattana shares through Prasit Pattana Public Company Limited and Ramkamhaeng Hospital Public Company Limited, a subsidiary and associated company respectively, the Company holds 28.17% of shares outstanding of Ake Udon Hospital.

The Company set up a subsidiary, "Bangkok Premier Life Insurance Broker Company Limited" with registered and paid-up capital of Baht 4.0 million (Baht 10 par value).

The Company invested in an additional 70,522,600 common shares of Bumrungrad Hospital Public Company Limited equal to 9.66% of registered and paid-up capital. Consequently, the Company now holds 174,350,200 shares or 23.88% of registered and paid-up capital of Bumrungrad Hospital Public Company Limited.

The Annual General Meeting of the Shareholders in 2012 approved the decrease of registered capital in the amount of Baht 7,932,525 from Baht 1,553,391,408. This resulted in new registered capital of Baht 1,545,458,883. The Meeting also approved increase in registered capital by way of a general mandate in the amount of Baht 154,545,888 from Baht 1,545,458,883, resulting in new registered capital of Baht 1,700,004,771for flexibility in raising capital for the business. However, to date, the Company has not increased capital through said general mandate.

Bangkok Dusit Medical Services Public Company Limited made a tender offer for all outstanding shares of Prasit Pattana Public Company Limited ("PYT") in order to delist shares of PYT from the Stock Exchange of Thailand with the Office of the Securities and Exchange Commission. After the tender offer, Prasit Pattana Public Company Limited delisted shares from the Stock Exchange of Thailand on 4th May 2012 and the Company now holds 98.32% of Prasit Pattana Public Company Limited.

The Company established a new 100% owned subsidiary under Bangkok Hospital Chiangmai Company Limited to construct a 200-bed hospital in Muang District, Chiangmai Province with registered capital of Baht 1,000 million and paid-up capital of Baht 250 million.

The Company established a new 100% owned subsidiary under Bangkok Hospital Udorn Company Limited to operate a 120-bed private hospital on Thongyai Road in Muang District, Udornthani Province with registered and paid-up capital of Baht 500 million. The subsidiary bought the business from Udorn Panyavej Hospital and officially commenced business as Bangkok Hospital Udorn on 12th December 2012, making it the 29th hospital in the Bangkok Hospital Group.

The Bangkok Hospital network is visionary in introducing technological innovation, namely ROBO DOCTOR or Remote Presence System from U.S.A., to increase efficiency of patient care. Patients have close and fast access to specialist physicians so that people in remote areas can be treated by standardized specialists. ROBO DOCTOR has been introduced in three hospitals, namely, Bangkok Hospital (Soi Soonvijai), Bangkok Hospital Phuket and Bangkok Hospital Pattaya to provide efficiency in patient referral and fast access to specialists. Patients and doctors are able to interact face-to-face and exchange information, which strengthens efficiency of care and confidence of the patients in accepting medical care.

Bangkok Hospital Medical Center and the College of Sports Science and Technology, Mahidol University received the FIFA Medical Centre of excellence Certificate from Jiri Dvorak, M.D., FIFA Chief Medical Officer. We are the first in Thailand and the ASEAN region and third in Asia (Japan, Qatar, Thailand and Saudi Arabia) to receive such honor. Currently, there are only 26 medical institutions around the world that have received such recognition. This clearly shows the continued dedication and role of Bangkok Hospital Medical Center in sports medicine. We have been responsible for taking care of the health of national football players and team members of the Thai premier league, in terms of medical care of injuries sustained by the athletes and rehabilitation as well as increasing physical fitness, preparation techniques before games and sports techniques for the greatest efficiency of the athletes, including nutrition and sports psychology.

Bangkok Hospital opened the Bangkok Academy of Sports and Exercise Medicine (BASEM) to strengthen our capabilities and raise the level of service with over Baht 70 million invested. BASEM was established to meet our objective of being the leader in health care, to meet the lifestyles of the new generation that like to exercise and play sports, as well as to provide care for sports-related injuries and analysis of problems in playing sports. The services include medical care of injuries sustained by the athletes and rehabilitation as well as increasing physical fitness, preparation techniques before games and sports techniques for the greatest efficiency of the athletes, including nutrition and sports psychology. Services in sports medicine will support Thailand's desire to be the medical hub and lead Bangkok Hospital to become the top sports medicine institute in ASEAN.

Bangkok Premier Life Insurance Broker, a subsidiary, which has expertise in health insurance within the Bangkok Hospital network, has joined hands with Muang Thai Life Assurance Company Limited to raise standard of living and health care by introducing an innovative life insurance product, health insurance and open up various channels of service. The cooperation has brought about newly developed health insurance policies that meet the needs of the consumers to access quality medical care while saving costs when in need.

The Phyathai Hospital Group and the Bangkok Hospital Group joined forces to open the Phyathai 3 Heart Center by Bangkok Heart Hospital with a budget of over Baht 100 million to expand client base in Thonburi area. Reiterating the Group's leadership in heart hospitals that meet international standards and the use of Off-Pump CABG. Moreover, the heart hospital provides complete service in health care and heart disease with state-of the-art technology and a team of specialists in all fields of heart disease to meet the international standards (JCI) and provide heart patients in the Thonburi area with the same level of service as received at Bangkok Heart Hospital. The Hospital provides complete diagnosis and treatment of heart and coronary disease from initial diagnosis, examination using special equipment, care and prevention of heart disease, surgery and after surgery recovery, as well as rehabilitation of the heart using internationally recognized modern medical equipment and technology.

The Bangkok Hospital Group joined forces with the Paolo Memorial Hospital Group to develop medical technology and medical services by opening the "Cancer Center" Paolo Memorial Hospital by Wattanosoth Hospital to meet the needs and lifestyles of patients as much as possible. The Center provides complete services in the prevention and treatment of cancer from detection of first stages of cancer, planning, treatment once detected to radiology to stop the spreading of cancer cells by a team of specialist doctors.

The Bangkok Spine Academy, Bangkok Hospital announced the success of a new surgical technique developed in Thailand to treat back pain through Direct Lateral Interbody Fusion (DLIF). The surgery treats back and leg pain caused by the spine pressing on the nerves or scoliosis. The distinctive points of this surgery are that it does not destroy the back muscles, less blood loss, small scar, and fast recovery. This technique uses Intraoperative Neuromonitoring sent through a 1-inch tube to monitor the nerves and spine. Then a replacement intervertebral disc is inserted making the spine stronger, enabling it to carry more body weight and lessening back pain. Moreover, the technique can effectively treat Spondylolisthesis or Scoliosis in elderly patients without having to make incisions along the back muscles, which may help lessen chronic back pain, median nerve entrapment, loose screws or loss of back muscle that occur after conventional surgery.

Bhumibol Adulyadej Hospital, Wattanosoth Hospital and Paolo Memorial Hospital Nawamin, being three public and private hospitals, joined together to organize the memorandum of understanding signing ceremony entitled "Out-Patient Referral for Radiology Treatment" for cancer patients using state-if-the-art medical technology to increase potential of radiology treatment for cancer patients of every group.

• The Company registered the long term land leasehold on Yaowarat Road with area of 1-0-99 rai including a 12,000 sq. m. building with the Best Fortune Property and Loan Fund for a period of 30 years. This was for the renovation of the land and building into a new private hospital under the name "Bangkok Hospital Chinatown". The hospital will provide selected tertiary care services and Advanced Emergency and Intermediate Care, and is expected to start operating in 2014.

• The Company has set up a new 100% owned subsidiary named, Bangkok Hospital Khon Khaen Company Limited with a registered and paid-up capital of Baht 600 million. The Company bought the Vechprasit Hospital building in Muang District, Khon Khaen Province and is renovating the building in order to open a new hospital under the name, Bangkok Hospital Khon Khaen. The new hospital is expected to open within 2014.

• The 2013 Annual General Meeting of the Shareholders on 18th April 2013 resolved to approve to extend the allocation of newly issued shares n under the General Mandate of no more than 154,545,888 shares at par value of Baht 1. The new shares are to be issued by the next Annual General Meeting of the Shareholders or within the date at which the law requires the next annual general meeting of the shareholders to be held , whichever comes first.

• The 2013 Annual General Meeting of the Shareholders on 18th April 2013 resolved to approve the purchase of shares of The Medic Pharma Company Limited from the existing shareholders. The Medic Pharma Company Limited was originally an associated company in which the company held 49% ownership. After the company purchased additional shares, the company's shareholding in the Medic Pharma Company Limited increased from 1,050,000 shares or 49% to 1,862,000 shares or 86.89% of the registered and paid-up capital.

• The Royal Bangkok Healthcare Company Limited (RBH), a 100% owned subsidiary, purchased shares of Krungthon Hospital (KDH) from some of the existing shareholders equal to 24.94% of the outstanding shares at Baht 55 per share. When combined with the existing KDH shares already held by the Company equal to 3,002,029 shares or 20%, RBH had to make a tender offer for all shares of KDH at the same price. After the tender offer, RBH held a total of 3,750,859 shares of KDH or 25.01%. This resulted in the ownership of 45.02% of KDH by the Bangkok Hospital Group. Consequently, Krungthon Hospital Public Company Limited registered its name change to "Thonburi Medical Center Public Company Limited" (Trading Name: KDH) and changed the name of the hospital to Samitivej Hospital Thonburi, making it the 30th hospital in the Bangkok Hospital Network.

• Later, at the KDH Extraordinary Shareholders' Meeting 1/2013 on 31st October 2013, the meeting approved the increase in registered capital of another Baht 75 million, resulting in registered capital increasing from Baht 150 million to Baht 225 million. The rights offering of 7.5 million shares at Baht 80 per share at 2:1, existing shares to new shares, garnered interest for only 4.384 million shares. While the Bangkok Hospital Group exercised its entire right to the new shares resulting in the increase of the Group's holding to 55.3% of the registered and paid-up capital after the rights offering (Baht 193.84 million).

• The Company set up a new wholly owned subsidiary named Bangkok Hospital Phitsanulok Company Limited with a registered and paid-up capital of Baht 600 million. On 1st October 2013, Phitsanulok Hospital purchased and took over the business of Rattanavej Hospital Company Limited, a private hospital in Muang District, Phitsanulok Province. The takeover was priced at Baht 576 million and the hospital reopened under the name "Bangkok Hospital Phitsanulok", making it the 31st hospital in the Bangkok Hospital Network. In addition, the company issued a rights offering under the general mandate for 3,636,771 shares to the existing shareholders of Rattanavej Hospital Company Limited through a private placement at Baht 127.22 per share totaling Baht 463 million. This increased the registered and paid-up capital from Baht 1,545,458,883 to Baht 1,549,095,654.

• The Company set up a new wholly owned subsidiary named Samitivej Chonburi Company Limited with a registered capital of Baht 600 million to operate a private hospital under the name "Samitivej Hospital Chonburi" in Muang District, Chonburi Province.

• The Company set up a new wholly owned subsidiary named Bangkok Hospital Surat Company Limited with a registered capital of Baht 300 million to operate a private hospital under the name "Bangkok Hospital Surat" in Muang District, Surat Thani Province.

• Bangkok Hospital Phuket Company Limited, a subsidiary in which the Company holds 99.69%, invested in the construction of a second hospital under the name "Deebuk Hospital" with total investment of approximately Baht 627 million and is expected to open within 2014.

• The Company has set up two holding companies in Singapore. The first holding company is BDMS Inter Pte. Ltd. with a registered capital of USD 40,000 and was set up for the Groups overseas investments. The second holding company is N Health Asia Pte. Ltd. with a registered capital of USD 40,000 and was set up for investments of the Group in offshore labs.
he investment in hospitals in the Lao People's Democratic Republic as well as investments in medical laboratories and equipment in the ASEAN region. The subsidiaries were set up through the holding company in Singapore and are as follows:
1. A subsidiary in the Lao People's Democratic Republic to invest in the construction of a hospital in Luang Prabang with a registered capital of about Baht 10 million and 100% owned by BDMS Inter Pte. Ltd. (Singapore).
2. N Health Myanmar Co., Ltd. with registered capital of USD 500,000 and 60% owned by N Health Asia Pte. Ltd. (Singapore).
3. N Health Laos Co., Ltd. with registered capital of USD 200,000 and 70% owned by with N Health Asia Pte. Ltd. (Singapore).
4. N Health Cambodia Co., Ltd. with registered capital of USD 320,000 and 100% owned by with N Health Asia Pte. Ltd. (Singapore).

BDMS hospital network expansion and investment in healthcare related companies

Medical Advancement and Development

Medical Cooperation

  1. Sano Hospital
    On 9th July 2014, Samitivej Public Company Limited, the Company subsidiary, signed an agreement with Sano Hospital, Japan for cooperation in studying and developing projects on gastrointestinal tract disease, as well as patient referrals, as appropriate to the illness, between the two hospitals.
  2. MD Anderson
    On 1st August 2014, Bangkok Dusit Medical Services Public Company Limited, Faculty of Medicine Siriraj Hospital and MD Anderson (University of Texas: MD Anderson Cancer Center – MDACC) signed an agreement on cooperation on the Global Academic Program (GAP), an academic and research project, as well as the MD Anderson Cancer Network Associate Project, a project on treatment of the disease. Later, on 16th November 2014, Wattanosoth Hospital and the Faculty of Medicine Siriraj Hospital became "Sister Institutes” of MDACC under GAP. The Company continues to achieve cooperation in treatment of cancer in the future.
  3. Stanford University
    On 6th August 2014, the Bangkok Orthopaedic Center, Bangkok Hospital and the Department of Orthopaedic Surgery, Standford University signed a Memorandum of Understanding to exchange knowledge and skills in the field of orthopaedics with a focus on excellence in the treatment of the musculoskeletal system. The cooperation also seeks to develop knowledge through research in orthopaedic surgery as well as improve the efficiency in the treatment of patients with such ailments. The signing of the agreement will lead to cooperation in studies, research and medical conferences to develop the potential of medical personnel.
  4. Oregon Health & Science University (OHSU)
    On 1st October 2014, Bangkok Dusit Medical Services Public Company Limited together with the Oregon Health & Science University (OHSU) established the BDMS-OHSU International Health Alliance to become an international medical center and elevate to a medical excellence center in all areas, especially in occupational health and pediatrics, in the Asia Paci􀅳c region.
  5. Heavy Ion Therapy
    On 9th October 2014, Wattanosoth Hospital, a hospital specializing in cancer, signed an agreement to collaborate with Universal Strategy Institute Limited Liability Company, Japan on the establishment of an irradiation center, which will use the "Heavy Ion Therapy” technology, as part of the plan to become the center for cancer treatment in the Asia Paci􀅳c region. The technology is state-of-the-art and effective in the treatment of cancer with shorter treatment time and fewer side effects. The treatment can be used with patients who are not suited to the conventional irradiation or for those who did not see results with the conventional irradiation. The advantage of this treatment is that it is highly accurate. The beams can destroy deep cancer cells with accuracy with the suitable amount of ions as the beam will relieve most of the energy on the position so that the amount of ions that passes through the body will have as little effect on the normal cells as possible.
  6. Nagoya University
    Bangkok Dusit Medical Services Public Company Limited together with Nagoya University, Japan signed an agreement on two significant items, (1) cooperation in studies through medical personnel exchanges for training in all fields of medicine and (2) referrals of patients between the University and the Hospital in the case that a patient should be travelling to Thailand (and neighboring countries) or to Nagoya (and nearby places).

Accreditation and Special Recognition

 

 

Expansion of BDMS network

Development in Medication

Awards Received

Medical Cooperation

  1. Sano Hospital
    Samitivej Public Company Limited, a company subsidiary, signed an agreement with Sano Hospital, Japan for cooperation in studying and developing projects on gastrointestinal tract disease, as well as patient referrals, as appropriate to the illness, between the two hospitals.
  2. MD Anderson
    Bangkok Dusit Medical Services Public Company Limited together with the Faculty of Medicine Siriraj Hospital collaborated to become a Sister Institution of MD Anderson Cancer Center (MDACC) of the University of Texas, U.S.A. under the Global Academic Program (GAP). This is the first time for collaboration among 3 institutions from public and private organizations in Thailand and the U.S.A., to support basic research and developments in safe and efficient treatment, as well as the exchange of knowledge and case studies across the regions, to provide happiness, quality of life, including the prevention and cure of cancer.
  3. Stanford
    The Bangkok Orthopaedic Center, Bangkok Hospital and the Department of Orthopaedic Surgery, Standford University signed a Memorandum of Understanding to exchange knowledge and skills in the field of orthopaedics with a focus on excellence in the treatment of the musculoskeletal system. The cooperation also seeks to develop knowledge through research in orthopaedic surgery as well as improve the efficiency in the treatment of patients with such ailments. The signing of the agreement will lead to cooperation in studies, research and medical conferences to develop the potential of medical personnel.
  4. OHSU
    BDMS with the Oregon Health & Science University (OHSU) established the BDMS-OHSU International Health Alliance to become an international medical center and elevate to a medical excellence center in all areas, especially in occupational health and pediatrics, in the Asia Pacific region.
  5. Heavy Ion Therapy
    Wattanosoth Hospital, a hospital specializing in cancer, signed an agreement to collaborate with Universal Strategy Institute Limited Liability Company, Japan on the establishment of an irradiation center, which will use the "Heavy Ion Therapy” technology, as part of the plan to become the center for cancer treatment in the Asia Pacific region. The technology is state-of-the-art and effective in the treatment of cancer with shorter treatment time and fewer side effects. The treatment can be used with patients who are not suited to the conventional irradiation or for those who did not see results with the conventional irradiation. The advantage of this treatment is that it is highly accurate. The beams can destroy deep cancer cells with accuracy with the suitable amount of ions as the beam will relieve most of the energy on the position so that the amount of ions that passes through the body will have as little effect on the normal cells as possible.
  6. Nagoya
    Bangkok Dusit Medical Services Public Company Limited together with Nagoya University, Japan signed an agreement on two significant items, (1) cooperation in studies through medical personnel exchanges for training in all fields of medicine and (2) referrals of patients between the University and the Hospital in the case that a patient should be travelling to Thailand (and neighboring countries) or to Nagoya (and nearby places). This is a great opportunity to enhance the potential of Thai medical personnel in order to be able to provide more internationally standardized services. A representative from the Japanese Embassy in Thailand was invited to witness the signing ceremony.
  7. Collaborated with one of the leading neurosurgeons
    BDMS has collaborated with Dr. Kieth L. Black, one of the leading neurosurgeons in the world and currently holds the position of Director of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center in Los Angeles, California. This collaboration has focused on researching and developing capabilities in treating diseases of the brain and nervous system, thus, enabling BDMS to become one of the most up-to-date medical centers in diseases of the brain and nervous system (neuroscience) in the Asia Pacific Region.
  8. Straumann
    Bangkok Hospital Dental Center has worked in collaboration with Straumann, a world-renown expert in implant, restorative and regenerative dentistry, in order to increase our efficiency in the dentistry implant and oral hygiene care. We have thus, been appointed as Straumann Partner Center Thailand.
  9. Doernbecher Children’s Hospital
    Samitivej Public Company Limited, a subsidiary, signed an alliance agreement with Doernbecher Children’s Hospital located in Oregon, U.S.A., a well-known children’s hospital awarded the highest rating for quality and safety in children’s health care in 2014 from the University Health System Consortium of hospitals for pediatric quality. Samitivej also opened the Samitivej International Children’s Hospital, both at Sukhumvit and Srinakarin, and has developed a Center of Excellence. Samitivej International Children’s Hospital has supported the national policy and direction of Thailand to become the medical hub of the Asia-Pacific Region.

Quality of Service

As at the end of 2014, the Company’s group of private hospitals includes 19 hospitals that have received national recognition by the As of the end of 2015, the Company’s network of private hospitals had received accreditation at various levels. A total of 22 hospitals were certified by Hospital Accreditation (HA) and 12 organizations (11 hospitals and 1 clinic) were certified by the Joint Commission International (JCI). Furthermore, Bangkok Hospital received Advanced HA, making us one of only three hospitals in Thailand to receive such an accreditation, the other two hospitals being Siriraj Hospital and Bhumibol Hospital.

 

 

Expansion of BDMS network

Honours and Awards

Medicine and Medical Care

Medical Cooperation

  1. Sano Hospital
    Samitivej Public Company Limited, a company subsidiary, signed an agreement with Sano Hospital, Japan for cooperation in studying and developing projects on gastrointestinal tract disease, as well as patient referrals, as appropriate to the illness, between the two hospitals.
  2. MD Anderson
    Bangkok Dusit Medical Services Public Company Limited together with the Faculty of Medicine Siriraj Hospital collaborated to become a Sister Institution of MD Anderson Cancer Center (MDACC) of the University of Texas, U.S.A. under the Global Academic Program (GAP). This is the first time for collaboration among 3 institutions from public and private organizations in Thailand and the U.S.A., to support basic research and developments in safe and efficient treatment, as well as the exchange of knowledge and case studies across the regions, to provide happiness, quality of life, including the prevention and cure of cancer.
  3. Stanford
    The Bangkok Orthopaedic Center, Bangkok Hospital and the Department of Orthopaedic Surgery, Standford University signed a Memorandum of Understanding to exchange knowledge and skills in the field of orthopaedics with a focus on excellence in the treatment of the musculoskeletal system. The cooperation also seeks to develop knowledge through research in orthopaedic surgery as well as improve the efficiency in the treatment of patients with such ailments. The signing of the agreement will lead to cooperation in studies, research and medical conferences to develop the potential of medical personnel.
  4. OHSU
    BDMS with the Oregon Health & Science University (OHSU) established the BDMS-OHSU International Health Alliance to become an international medical center and elevate to a medical excellence center in all areas, especially in occupational health and pediatrics, in the Asia Pacific region.
  5. Heavy Ion Therapy
    Wattanosoth Hospital, a hospital specializing in cancer, signed an agreement to collaborate with Universal Strategy Institute Limited Liability Company, Japan on the establishment of an irradiation center, which will use the "Heavy Ion Therapy” technology, as part of the plan to become the center for cancer treatment in the Asia Pacific region. The technology is state-of-the-art and effective in the treatment of cancer with shorter treatment time and fewer side effects. The treatment can be used with patients who are not suited to the conventional irradiation or for those who did not see results with the conventional irradiation. The advantage of this treatment is that it is highly accurate. The beams can destroy deep cancer cells with accuracy with the suitable amount of ions as the beam will relieve most of the energy on the position so that the amount of ions that passes through the body will have as little effect on the normal cells as possible.
  6. Nagoya
    Bangkok Dusit Medical Services Public Company Limited together with Nagoya University, Japan signed an agreement on two significant items, (1) cooperation in studies through medical personnel exchanges for training in all fields of medicine and (2) referrals of patients between the University and the Hospital in the case that a patient should be travelling to Thailand (and neighboring countries) or to Nagoya (and nearby places). This is a great opportunity to enhance the potential of Thai medical personnel in order to be able to provide more internationally standardized services. A representative from the Japanese Embassy in Thailand was invited to witness the signing ceremony.
  7. Collaborated with one of the leading neurosurgeons
    BDMS has collaborated with Dr. Kieth L. Black, one of the leading neurosurgeons in the world and currently holds the position of Director of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center in Los Angeles, California. This collaboration has focused on researching and developing capabilities in treating diseases of the brain and nervous system, thus, enabling BDMS to become one of the most up-to-date medical centers in diseases of the brain and nervous system (neuroscience) in the Asia Pacific Region.
  8. Straumann
    Bangkok Hospital Dental Center has worked in collaboration with Straumann, a world-renown expert in implant, restorative and regenerative dentistry, in order to increase our efficiency in the dentistry implant and oral hygiene care. We have thus, been appointed as Straumann Partner Center Thailand.
  9. Doernbecher Children’s Hospital
    Samitivej Public Company Limited, a subsidiary, signed an alliance agreement with Doernbecher Children’s Hospital located in Oregon, U.S.A., a well-known children’s hospital awarded the highest rating for quality and safety in children’s health care in 2014 from the University Health System Consortium of hospitals for pediatric quality. Samitivej also opened the Samitivej International Children’s Hospital, both at Sukhumvit and Srinakarin, and has developed a Center of Excellence. Samitivej International Children’s Hospital has supported the national policy and direction of Thailand to become the medical hub of the Asia-Pacific Region.
  10. Missouri Orthopedic Institute, University of Missouri, U.S.A.
    Bangkok Dusit Medical Services Public Company Limited and the Missouri Orthopedic Institute signed an agreement to collaborate in the exchange of knowledge and skills in orthopedics between the Bangkok Orthopedic Center at Bangkok Hospital and the Missouri Orthopedic Institute at the University of Missouri, U.S.A., through various activities such as academic conferences to continuously improve our personnel as well as supporting research in orthopedics and other medical cooperation. This collaboration shall improve the efficiency of orthopedic patient care.
  11. Hannover Medical School, Germany
    Bangkok Dusit Medical Services Public Company Limited and the Hannover Medical School signed an agreement to collaborate in the exchange of knowledge and skills in orthopedics and trauma surgery between the Bangkok Orthopedic Center at Bangkok Hospital and the Department of Orthopedics and Trauma at Hannover Medical School, Germany. Through the agreement, we have organized medical seminars, as well as sent physicians and nurses to Hannover Medical School for short-term and long-term training in order to continuously develop the capabilities of our personnel and support research in orthopedics and trauma to improve efficiency of orthopedic and trauma patient care.
  12. Collaboration between Samitivej Children’s Hospital and Takatsuki Hospital Japan
    Samitivej Children’s Hospital, a subsidiary, and Takatsuki Hospital, Japan signed and alliance agreement in pediatrics and neonatal intensive care unit (NICU) to develop medical personnel and exchange experiences in order to further the potential of Samitivej, better the quality of life of child patients and provide comprehensive medical care that meet international standards.
  13. N Health Pathology Company Limited together with the Royal College of Pathologists of Thailand organized the Interhospital Renal Clinicopathological Conference
    N Health Pathology Company Limited together with the Royal College of Pathologists of Thailand organized the Interhospital Renal Clinicopathological Conference 1/2016 giving the opportunity to over 50 kidney and pathology specialists as well as resident physicians from various medical schools and hospitals in Thailand to share interesting case studies to enhance diagnostics and treatment. The kidney academic conference shall be held every two months,

Quality of Service

At the end of 2016, the Group had a total of 31 hospitals within the network that had received accreditation from Hospital Accreditation Thailand (HA). In addition, 14 hospitals had received accreditation from Joint Commission International (JCI). Bangkok Hospital also received Advanced HA Accreditation. The hospitals are listed below:

Expanding network of hospitals and business, medical support

Medicine and Medical Care

Awards

Medical Cooperation

  1. Sano Hospital
    Samitivej Public Company Limited, a company subsidiary, signed an agreement with Sano Hospital, Japan for cooperation in studying and developing projects on gastrointestinal tract disease, as well as patient referrals, as appropriate to the illness, between the two hospitals.
  2. MD Anderson
    Bangkok Dusit Medical Services Public Company Limited together with the Faculty of Medicine Siriraj Hospital collaborated to become a Sister Institution of MD Anderson Cancer Center (MDACC) of the University of Texas, U.S.A. under the Global Academic Program (GAP). This is the first time for collaboration among 3 institutions from public and private organizations in Thailand and the U.S.A., to support basic research and developments in safe and efficient treatment, as well as the exchange of knowledge and case studies across the regions, to provide happy, quality lives, including the prevention and cure of cancer.
  3. Stanford University
    The Bangkok Orthopedic Center, Bangkok Hospital and the Department of Orthopedic Surgery, Stanford University signed a Memorandum of Understanding to exchange knowledge and skills in the field of orthopedics with a focus on excellence in the treatment of the musculoskeletal system. The cooperation also seeks to develop knowledge through research in orthopedic surgery as well as improve the efficiency in the treatment of patients with such ailments. The signing of the agreement will lead to cooperation in studies, research and medical conferences to develop the potential of medical personnel.
  4. Oregon Health & Science University (OHSU)
    Bangkok Dusit Medical Services Public Company Limited together with the Oregon Health & Science University (OHSU) established the BDMS-OHSU International Health Alliance to become an international medical center and elevate to a medical excellence center in all areas, especially in occupational health, pediatrics, rehabilitation, clinical simulation and preventive cardiology, in the Asia Pacific region.
  5. Heavy Ion Therapy (อนุภาคบำบัด)
    Wattanosoth Hospital, a hospital specializing in cancer, signed an agreement to collaborate with Universal Strategy Institute Limited Liability Company, Japan on the establishment of an irradiation center, which will use the “Heavy Ion Therapy” technology, as part of the plan to become the center for cancer treatment in the Asia Pacific region. The technology is state-of-the-art and effective in the treatment of cancer with shorter treatment time and fewer side effects. The treatment can be used with patients who are not suited to the conventional irradiation or for those who did not see results with the conventional irradiation. The advantage of this treatment is that it is highly accurate. The beams can destroy deep cancer cells with accuracy with the suitable amount of ions as the beam will relieve most of the energy on the position so that the amount of ions that passes through the body will have as little effect on the normal cells as possible.
  6. Nagoya University
    Bangkok Dusit Medical Services Public Company Limited together with Nagoya University, Japan signed an agreement on two significant items, (1) cooperation in studies through medical personnel exchanges for training in all fields of medicine and (2) referrals of patients between the University and the Hospital in the case that a patient should be travelling to Thailand (and neighboring countries) or to Nagoya (and nearby places). This is a great opportunity to enhance the potential of Thai medical personnel in order to be able to provide more internationally standardized services. A representative from the Japanese Embassy in Thailand was invited to witness the signing ceremony.
  7. Collaboration with World Leading Neurosurgeon
    BDMS has collaborated with Dr. Keith L. Black, Director of the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center in Los Angeles, California. This collaboration has focused on researching and developing capabilities in treating diseases of the brain and nervous system, thus, enabling BDMS to become one of the most up-to-date medical centers in diseases of the brain and nervous system (neuroscience) in the Asia Pacific Region.
  8. Collaboration with The Straumann Group
    Bangkok Hospital Dental Center has worked in collaboration with The Straumann Group, a world-renown expert in implant, restorative and regenerative dentistry, in order to increase our efficiency in the dentistry implant and oral hygiene care. We have thus, been appointed as Straumann Partner Center Thailand.
  9. Doernbecher Children’s Hospital
    Samitivej Public Company Limited, a subsidiary, signed an alliance agreement with Doernbecher Children’s Hospital located in Oregon, U.S.A., a well-known children’s hospital awarded the highest rating for quality and safety in children’s health care in 2014 from the University Health System Consortium of hospitals for pediatric quality. Samitivej also opened the Samitivej International Children’s Hospital, both at Sukhumvit and Srinakarin, and has developed a Center of Excellence. Samitivej International Children’s Hospital has supported the national policy and direction of Thailand to become the medical hub of the Asia-Pacific Region.
  10. Missouri Orthopedic Institute, University of Missouri, U.S.A.
    Bangkok Dusit Medical Services Public Company Limited and the Missouri Orthopedic Institute signed an agreement to collaborate in the exchange of knowledge and skills in orthopedics between the Bangkok Orthopedic Center at Bangkok Hospital and the Missouri Orthopedic Institute at the University of Missouri, U.S.A., through various activities such as academic conferences to continuously improve our personnel as well as supporting research in orthopedics and other medical cooperation. This collaboration shall improve the efficiency of orthopedic patient care.
  11. Hannover Medical School, Germany
    Bangkok Dusit Medical Services Public Company Limited and the Hannover Medical School signed an agreement to collaborate in the exchange of knowledge and skills in orthopedics and trauma surgery between the Bangkok Orthopedic Center at Bangkok Hospital and the Department of Orthopedics and Trauma at Hannover Medical School, Germany. Through the agreement, we have organized medical seminars, as well as sent physicians and nurses to Hannover Medical School for short-term and long-term training in order to continuously develop the capabilities of our personnel and support research in orthopedics and trauma to improve efficiency of orthopedic and trauma patient care.
  12. Collaboration between Samitivej Children’s Hospital and Takatsuki Hospital Japan
    Samitivej Children’s Hospital, a subsidiary, and Takatsuki Hospital, Japan signed and alliance agreement in pediatrics and neonatal intensive care unit (NICU) to develop medical personnel and exchange experiences in order to further the potential of Samitivej, better the quality of life of child patients and provide comprehensive medical care that meet international standards.
  13. N Health Pathology Company Limited together with the Royal College of Pathologists of Thailand organized the Interhospital Renal Clinicopathological Conference
    N Health Pathology Company Limited together with the Royal College of Pathologists of Thailand has organized the Interhospital Renal Clinicopathological Conference since 2016 giving the opportunity to over 50 kidney and pathology specialists as well as resident physicians from various medical schools and hospitals in Thailand to share interesting case studies to enhance diagnostics and treatment. The kidney academic conference shall be held three times a year.

Quality of Service

At the end of 2017, the Group had a number of hospitals within the network that had received accreditation from Hospital Accreditation Thailand (HA) and Joint Commission International (JCI). Bangkok Hospital also received Advanced HA Accrediation. The hospitals are listed below:


Bangkok Hospital Medical Center, 2 Soi Soonvijai 7, New Petchburi Rd., Bangkok, Thailand 10310 Tel. (+66) 2310-3102
Please read our General Disclaimer & Warning carefully.Use of this Website constitutes acceptance of the Terms of Website Use.
Copyright © 2024. ThaiListedCompany.com. All Rights Reserved.